NCT05961709View on ClinicalTrials.gov

The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2028

Conditions
Colon Cancer
Interventions
DRUG

Cemiplimab

Given by IV (vein)

Trial Locations (5)

32207

RECRUITING

Baptist - MD Anderson Cancer Center, Jacksonville

70121

RECRUITING

Ochsner, New Orleans

77030

RECRUITING

M D Anderson Cancer Center, Houston

85234

RECRUITING

Banner - MD Anderson Cancer, Gilbert

08103

RECRUITING

Cooper University Medical Center, Camden

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER